Drug recall · June 29, 2022
Testosterone Cypionate Injection recall
Why: Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-015-40.
- Lots / codes
Lot: HAC3427A, EXP Date: 08/2023
- Quantity
- 47,500 vials
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- Nationwide within the United States
- Initiated
- June 10, 2022 · Voluntary: Firm initiated
- Classified
- June 22, 2022
- Reported
- June 29, 2022
- Ended
- July 25, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Testosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.